ABBV 241011 197.50C (ABBV241011C197500) Stock Options, News & Quotes

US OptionsDetailed Quotes

ABBV241011C197500

Watchlist

0.43
-0.29-40.28%

15min DelayClose Oct 7 16:00 ET

0.90High0.40Low

Intraday

5D
Daily

News

TD Cowen Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $225
Moomoo News00:32 ET · Ratings
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
Benzinga15:00 ET
AbbVie Is Maintained at Buy by TD Cowen
Dow Jones13:49 ET · Ratings
AbbVie Analyst Ratings
Benzinga13:37 ET · Ratings
AbbVie Insiders Sell US$56m Of Stock, Possibly Signalling Caution
Simply Wall StOct 7 10:49 ET
Express News | Abbvie : TD Cowen Raises Target Price to $225 From $195
ReutersOct 7 08:34 ET

Comments

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Aggressive 50bp rate cut: How long will the market frenzy last?

In One Chart

Aug 22 07:58

Columns In One Chart | Wall Street Eyes New Sectors for the Next Stock Market Surge

Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...